Literature DB >> 3824563

Granular cell myoma and schwannoma: fine structural and immunohistochemical study.

P Abenoza, R K Sibley.   

Abstract

We present the histological, ultrastructural, and immunohistochemical findings of two granular cell tumors of different histogenesis: a mediastinal granular cell schwannoma, and an uterine granular cell leiomyoma. Ultrastructurally the mediastinal tumor showed granular cell changes of the Schwann cells which were reactive for S-100 protein and Leu 7 antigen, but not for actin, desmin, CEA, EMA, or cytokeratin. Ultrastructural study of the uterine lesion demonstrated smooth muscle cells with only a few "autophagic" facuoles to cells nearly replaced by lysosomes. Immunohistochemically this tumor showed reactivity for actin, desmin, and Leu 7 antigen, but was S-100 protein, CEA, EMA, and cytokeratin negative.

Entities:  

Mesh:

Year:  1987        PMID: 3824563     DOI: 10.3109/01913128709023179

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  4 in total

1.  Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: an ultrastructural and immunohistochemical analysis.

Authors:  B P Eyden; R J Hale; I Richmond; C H Buckley
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Solitary, multiple, benign, atypical, or malignant: the "Granular Cell Tumor" puzzle.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

Review 3.  Primary cutaneous malignant granular cell tumor: a case report in China and review of the literature.

Authors:  Ting-ting Liu; Yang Han; Song Zheng; Bo Li; Yu-qi Liu; Yi-xian Chen; Yong-feng Liu; En-hua Wang
Journal:  Diagn Pathol       Date:  2015-07-19       Impact factor: 2.644

Review 4.  Mesenchymal tumours of the mediastinum--part II.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.